Search

everythinglearnresearchcommunity

for

Search:↓

Tetrathiomolybdate reduces hair growth marker in skin cells by boosting harmful oxygen molecules, but effects can be reversed.

Antiandrogens may help treat conditions like excessive hair growth, prostate tumors, male baldness, and acne by blocking male hormone effects.

Psychotropic drugs can help treat skin conditions affected by mental health, but dermatologists must use them carefully due to side effects and patient concerns.

Baricitinib is effective as a treatment for severe hair loss.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

New retinoids are effective for various skin conditions and are being developed to have fewer side effects.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Dermatological treatments can have significant side effects, including allergic reactions, sexual dysfunction, and increased cancer risk.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

A woman's sudden hair loss was linked to azathioprine use despite normal enzyme levels, and improved after stopping the drug and starting treatment.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

A woman with Hashimoto's hypothyroidism developed Graves' hyperthyroidism after 20 years, showing these conditions may be linked.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

The treatment was not recommended due to limited effectiveness and significant side effects.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Combining antihistamines with topical treatment improves hair regrowth in alopecia areata.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.

A woman in Sri Lanka was diagnosed with lupus after presenting with protein loss from the gut and other symptoms.

Alopecia areata does not affect areas with psoriasis plaques.

Methotrexate is not proven to maintain remission in ulcerative colitis.